₹1,404.95
-10.90 (-0.77%)
As of 17 Sept 2026, Global Health Ltd share price is ₹1,404.95. The stock opened at ₹1,404.95 and had closed at ₹1,415.85 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹955.20 and a high of ₹1,542.00. In terms of performance, Global Health Ltd share price has increased by 34.22% over the past six months and has increased by 2.74% over the last year.
MEDANTA Stock Price Chart
Global Health Ltd Overview
Market cap₹37,775 Crs
Volume7,072
Prev. Close₹1,415.85
Year range₹955.20 - ₹1,542.00
ISININE474Q01031
About MEDANTA
Global Health is engaged in the business of providing healthcare services.
Global Health Ltd Historical Performance
1 Month Return-0.64%
6 Month Return34.98%
3 Year Return99.94%
3 Month Return13.72%
1 Year Return3.31%
5 Year Return-
Global Health Ltd Fundamentals
ROCE(TTM)14.57%
P/E Ratio (TTM)78.45
P/B Ratio9.41
Debt to Equity0.06
ROE12.37%
EPS (TTM)18.48
Dividend Yield0.04%
Book Value149.24
Profit Margin12.72%
Operating Margin15.30%
Global Health Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 3,815.79 | 3,294.96 | 3,065.31 | 2,021.13 | 1,800.00 |
| EBITDA | 861.65 | 806.05 | 835.20 | 463.96 | 410.58 |
| Net Profit | 496.20 | 461.53 | 486.35 | 263.25 | 218.79 |
| EPS | 18.46 | 17.18 | 13.44 | 10.16 | 8.68 |
Global Health Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,399.97 |
| Resistance 1 (R1) | 1,442.37 |
| Pivot Point | 1,426.48 |
Global Health Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 14-Aug-2026 | 14-May-2026 | 14-Aug-2026 | Final | ₹0.50 |
| 22-Aug-2025 | 15-May-2025 | 22-Aug-2025 | Final | ₹0.50 |
MEDANTA Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Naresh Kumar Trehan | Chairman & Managing Director |
| Pankaj Prakash Sahni | Chief Executive Officer |
| Hari S Bhartia | Non Executive Independent Director |
Global Health Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,696.50-0.20% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,025.00-0.49% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹870.30-1.11% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Global Health Ltd today is ₹1,404.95 on NSE and ₹1,404.95 on BSE.
- The 52-week high of Global Health Ltd is ₹1,542.00, while the 52-week low is ₹955.20.
- The current market capitalisation of Global Health Ltd is approximately ₹37,775 crore.
- The P/E (Price-to-Earnings) ratio of Global Health Ltd is 58.06. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Global Health Ltd is 8.05. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Global Health Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for MEDANTA on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Global Health Ltd has delivered a return of approximately 99.94%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Global Health Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 33.00% promoters, -6.57% FIIs, 16.89% DIIs, and 5.60% public shareholders.

